🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/11/2012 | 11,71 | 11,91 | 11,57 | 11,90 | +1,76% | 2,93% | 221.214 |
| 20/11/2012 | 11,85 | 11,94 | 11,54 | 11,69 | -1,73% | 3,37% | 331.661 |
| 19/11/2012 | 11,23 | 12,21 | 11,00 | 11,90 | +14,40% | 10,72% | 1.890.578 |
| 16/11/2012 | 10,57 | 10,72 | 10,19 | 10,40 | -1,88% | 5,08% | 281.006 |
| 15/11/2012 | 11,00 | 11,00 | 10,47 | 10,60 | -3,41% | 4,76% | 202.138 |
| 14/11/2012 | 11,10 | 11,23 | 10,71 | 10,97 | -1,18% | 4,66% | 117.019 |
| 13/11/2012 | 10,34 | 11,19 | 10,32 | 11,10 | +7,55% | 8,32% | 262.892 |
| 12/11/2012 | 10,46 | 10,51 | 10,24 | 10,32 | -0,72% | 2,56% | 85.440 |
| 09/11/2012 | 10,23 | 10,66 | 10,09 | 10,40 | +1,71% | 5,61% | 71.334 |
| 08/11/2012 | 10,50 | 10,50 | 10,07 | 10,22 | -2,61% | 4,04% | 105.958 |
| 07/11/2012 | 11,09 | 11,15 | 10,39 | 10,50 | -6,13% | 6,81% | 296.395 |
| 06/11/2012 | 10,95 | 11,50 | 10,62 | 11,19 | +4,12% | 7,98% | 297.837 |
| 05/11/2012 | 10,35 | 10,89 | 10,11 | 10,74 | +6,43% | 7,59% | 278.441 |
| 02/11/2012 | 9,65 | 10,12 | 9,65 | 10,09 | +4,46% | 4,91% | 229.229 |
| 01/11/2012 | 9,66 | 9,94 | 9,63 | 9,66 | +0,45% | 3,23% | 80.631 |
| 31/10/2012 | 9,49 | 9,76 | 9,20 | 9,62 | +1,12% | 5,85% | 150.201 |
| 26/10/2012 | 9,59 | 9,65 | 9,40 | 9,51 | -0,78% | 2,60% | 208.550 |
| 25/10/2012 | 9,83 | 10,03 | 9,43 | 9,59 | -2,04% | 6,15% | 110.447 |
| 24/10/2012 | 9,86 | 9,93 | 9,61 | 9,79 | -0,44% | 3,29% | 77.585 |
| 23/10/2012 | 9,86 | 9,88 | 9,59 | 9,83 | -0,88% | 2,91% | 180.177 |
| 22/10/2012 | 9,76 | 9,92 | 9,62 | 9,92 | +1,73% | 3,07% | 158.056 |
| 19/10/2012 | 10,11 | 10,12 | 9,57 | 9,75 | -3,99% | 5,49% | 203.902 |
| 18/10/2012 | 10,52 | 10,59 | 10,13 | 10,16 | -3,78% | 4,33% | 87.043 |
| 17/10/2012 | 10,57 | 10,62 | 10,47 | 10,56 | -0,24% | 1,42% | 62.196 |
| 16/10/2012 | 10,67 | 10,70 | 10,51 | 10,58 | -0,06% | 1,81% | 61.716 |
| 15/10/2012 | 10,59 | 10,63 | 10,51 | 10,59 | -0,18% | 1,12% | 76.143 |
| 12/10/2012 | 10,67 | 10,75 | 10,46 | 10,61 | -0,64% | 2,75% | 76.143 |
| 11/10/2012 | 10,95 | 11,01 | 10,66 | 10,67 | -1,61% | 3,19% | 108.844 |
| 10/10/2012 | 10,88 | 10,94 | 10,70 | 10,85 | +0,12% | 2,12% | 98.424 |
| 09/10/2012 | 11,02 | 11,07 | 10,66 | 10,84 | -1,86% | 3,68% | 125.355 |